ConductScience.org, home

Gene · 1760

NIH grants1,542

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleDMPK papersNewest fiscal year
R01NS098819Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD132025
P30CA016672Cancer Center Support Grant82025
R01MH062646Regulation of Signaling by mGluR582025
R35NS116846Design of Precision Small Molecules Targeting RNA Repeating Transcripts to Manipulate and Study Disease Biology82025
ZIACP010144Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes82025
R35GM118103Recognition of Cellular Targets by single and double-stranded nucleic acids72025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant62025
R01NS031373Functions of Metabotropic Glutamate Receptor Subtypes62025
R01NS103172Therapeutic strategies for microsatellite expansion diseases using RNA targeting62025
P30EY030413Core Grant for Vision Research52025
R01NS104010Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal)52025
P01CA092584Structural Cell Biology of DNA Repair Machines42025
P30DK056338Texas Medical Center Digestive Diseases Center42025
R01HD036071Genotype-Phenotype Relationships in Fragile X Families42025
R01NS099280Hexanucleotide repeat translation in ALS and Frontotemporal Dementia42025
ZIADK057602The consequences of the unusual mutation responsible for the Repeat Expansion Diseases42025
P30CA006973Regional Oncology Research Center32025
P30CA008748Cancer Center Support Grant32025
R01AR045203D4Z4 Coding Transcripts and FSHD32025
R01DK114356Metabolic Impacts of Type II Interferon Signals in Obesity32025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1760/grants